The National Cancer Center of Japan, well established as a leader both in clinical practice and in research for over five decades, is welcoming partners for drug development. With abundant genomic and clinical data, biobank samples collected under the universal healthcare system in Japan, and expertise with drug approval from authorities, we can serve as your trusted gateway to Asia.